Data e luogo: Hotel Metropole Suisse, Piazza Camillo Benso Conte di Cavour, 19 Como (CO) – 23 novembre 2024
Corso ECM: ID 2157- 429649 ACCREDITATO PRESSO LA COMMISSIONE NAZIONALE PER LA FORMAZIONE CONTINUA
Attribuiti 6 Crediti Formativi
Responsabili Scientifici: Giuseppe Valmadre, Clelia Casartelli, Diego Luigi Cortinovis, Enrica Capelletto
Professioni accreditate: Medico chirurgo (Discipline: Oncologia, Anatomia Patologica, Malattie dell’apparato Respiratorio, Chirurgia Toracica, Chirurgia Generale, Patologia Clinica, Radiodiagnostica, Radioterapia, Medicina Interna, Medicina Nucleare), Biologo.
Durata corso: 6 ore
Razionale:
Neoplastic lung disease is a field of medical oncology that is constantly evolving, both from a biomolecular and a therapeutic point of view.
These innovations, however, risk not being implemented in clinical practice, generating an inevitable separation between the scientific world and realistically applicable therapeutic opportunities.
In this scenario, the concept of multidisciplinarity related to the innovation that each medical specialty can offer, enriches and increases what can be offered to patients suffering from thoraco-pulmonary neoplastic diseases.
Event 2024 aims to give space for a wide discussion, starting with frontal reports with the objective of assessing how many of these innovations can be applied in daily clinical practice to improve the survival and quality of life of patients.
